DexTech Medical AB announces prospectus due to upcoming rights issue
DexTech Medical AB (“DexTech” or “the Company”) hereby publishes a prospectus in connection with the Company's forthcoming rights issue, the subscription period of which begins on Wednesday, December 8, 2021. The prospectus has today been approved and registered by Finansinspektionen and will be available at Finansinspektionen (www.fi .se) and Spotlight Stock Markets (www.spotlightstockmarket.com) respectively websites. The prospectus is also available on the Company's (www.dextechmedical.com), Sedermera Fondkommissions (www.sedermera.se) and Nordic Issuings (www.nordic-issuing.se) websites